Kim L. O'Neill
Jump to navigation
Jump to search
This article has multiple issues. Please help improve it or discuss these issues on the talk page. (Learn how and when to remove these template messages)
|
Kim L. O'Neill is the developer of a monoclonal antibody that allows for the accurate, cheap and easy detection of cancer.
O'Neill has a B.Sc. degree from New University of Ulster and a Ph.D. from the University of Ulster. He is a full professor of microbiology at Brigham Young University. In 1998 research by O'Neill suggested a link between caffeine and the formation of some cancers.[1] O'Neill has served as associate director of BYU's cancer research center.
O'Neill is also a convert to The Church of Jesus Christ of Latter-day Saints, having joined the church in Ireland.
Sources
Categories:
- Articles with short description
- Short description with empty Wikidata description
- BLP articles lacking sources from July 2012
- All BLP articles lacking sources
- Articles lacking in-text citations from July 2012
- All articles lacking in-text citations
- Articles with topics of unclear notability from July 2012
- All articles with topics of unclear notability
- Academics articles with topics of unclear notability
- Articles with multiple maintenance issues
- AC with 0 elements
- Alumni of Ulster University
- Brigham Young University faculty
- Converts to Mormonism
- Irish Latter Day Saints
- Irish biologists
- Living people
- Irish emigrants to the United States
- Year of birth missing (living people)